back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-03-19 12:17 Tx date 2025-03-17 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$100,250
+25,000 vol $4.01 each |
226,729 | |
| Filed 2024-05-15 11:29 Tx date 2024-05-13 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$137,900
+35,000 vol $3.94 each |
201,729 | |
| Filed 2023-11-27 08:48 Tx date 2023-11-08 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-18,000 vol |
9,720 | |
| Filed 2023-08-23 12:57 Tx date 2023-08-22 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$164,500
+35,000 vol $4.70 each |
166,729 | |
| Filed 2022-12-15 15:29 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$49,730
+4,973 vol $10.00 each |
27,720 | |
| Filed 2022-12-15 15:28 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$106,810
+10,086 vol $10.59 each |
131,729 | |
| Filed 2021-12-10 14:58 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$47,470
+4,747 vol $10.00 each |
22,747 | |
| Filed 2021-12-10 14:57 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$103,639
+6,859 vol $15.11 each |
121,643 | |
| Filed 2020-11-13 14:58 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$180,000
+18,000 vol $10.00 each |
18,000 | |
| Filed 2020-11-13 14:58 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-11-13 12:44 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$155,600
+10,000 vol $15.56 each |
114,784 | |
| Filed 2019-12-09 13:49 Tx date 2019-12-05 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,745
+100 vol $17.45 each |
49,700 | |
| Filed 2019-12-09 13:49 Tx date 2019-12-05 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,761
+100 vol $17.61 each |
49,600 | |
| Filed 2019-06-11 10:57 Tx date 2019-06-07 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$187,361
+12,049 vol $15.55 each |
104,784 | |
| Filed 2018-08-23 Tx date 2018-08-22 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$141,571
+16,975 vol $8.34 each |
92,735 | |
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
49,500 | ||
| Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Gross, Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
75,760 |